“…The hairline recession in FFA and the frequent concomitant androgenetic alopecia (AGA) that occurs in patients with LPP and FFA have led some authors to propose a role for androgen excess in FFA, largely on the basis of the postmenopausal predominance of affected females ( Dawn et al., 2003 ; Ranasinghe et al., 2017 ). Although definitive evidence for this hypothesis is missing, reports of clinical benefits seen in some patients treated with 5α-reductase inhibitors (5ARIs) such as dutasteride ( Jerjen et al., 2021 ; Lobato-Berezo et al., 2018 ; Panchaprateep et al., 2020 ; Pindado-Ortega et al., 2021 ; Vañó-Galván et al., 2016 ) have been interpreted as supporting it. However, the results of retrospective cohort studies of moderate quality where patients were treated with concomitant therapies in addition to 5ARIs and/or serum androgen and estrogen levels were not measured should be interpreted cautiously ( Murad and Bergfeld, 2021 ).…”